Ameriprise Financial Inc Vanda Pharmaceuticals Inc. Transaction History

Ameriprise Financial Inc

$375 Billion
Q4 2024

A detailed history of Ameriprise Financial Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 191,220 shares of VNDA stock, worth $910,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares

191,220

Previous 241,986 20.98%

Holding current value

$910,207

Previous $1.13 Million 19.31%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$4.41 - $5.46 $223,878 - $277,182	-50,766 Reduced 20.98%	191,220 $915,000
Q3 2024 Nov 14, 2024	SELL	$4.61 - $6.34 $9,243 - $12,711	-2,005 Reduced 0.82%	241,986 $1.13 Million
Q2 2024 Aug 14, 2024	SELL	$3.91 - $6.5 $977 - $1,625	-250 Reduced 0.1%	243,991 $1.38 Million
Q1 2024 May 15, 2024	SELL	$3.47 - $4.61 $190,787 - $253,467	-54,982 Reduced 18.37%	244,241 $1 Million
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $1.12 Million - $1.52 Million	-330,927 Reduced 52.52%	299,223 $1.26 Million
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $1.88 Million - $2.88 Million	-438,806 Reduced 41.05%	630,150 $2.72 Million
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $459,674 - $541,481	77,911 Added 7.86%	1,068,956 $7.04 Million
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $920,164 - $1.19 Million	148,894 Added 17.68%	991,045 $6.73 Million
Q4 2022 Feb 14, 2023	SELL	$6.87 - $10.96 $482,081 - $769,085	-70,172 Reduced 7.69%	842,151 $6.22 Million
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $1.23 Million - $1.53 Million	129,898 Added 16.6%	912,323 $9.02 Million
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $152,022 - $193,335	-16,329 Reduced 2.04%	782,425 $8.53 Million
Q1 2022 May 16, 2022	BUY	$10.84 - $16.55 $427,887 - $653,278	39,473 Added 5.2%	798,754 $9.03 Million
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $6 Million - $8.09 Million	382,668 Added 101.61%	759,281 $11.9 Million
Q3 2021 Nov 15, 2021	BUY	$15.35 - $21.27 $129,185 - $179,008	8,416 Added 2.29%	376,613 $6.45 Million
Q2 2021 Aug 16, 2021	BUY	$15.71 - $21.51 $500,991 - $685,953	31,890 Added 9.48%	368,197 $7.92 Million
Q1 2021 May 17, 2021	SELL	$13.42 - $20.28 $764,926 - $1.16 Million	-56,999 Reduced 14.49%	336,307 $5.05 Million
Q4 2020 Feb 12, 2021	SELL	$9.77 - $13.81 $651,483 - $920,878	-66,682 Reduced 14.5%	393,306 $5.17 Million
Q3 2020 Nov 16, 2020	BUY	$9.32 - $12.02 $862,752 - $1.11 Million	92,570 Added 25.19%	459,988 $4.44 Million
Q2 2020 Aug 14, 2020	SELL	$9.66 - $12.02 $45,247 - $56,301	-4,684 Reduced 1.26%	367,418 $4.2 Million
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $128,025 - $286,776	17,070 Added 4.81%	372,102 $3.86 Million
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $59,473 - $83,925	-4,804 Reduced 1.34%	355,032 $5.83 Million
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $290,246 - $373,512	-23,655 Reduced 6.17%	359,836 $4.78 Million
Q2 2019 Aug 14, 2019	SELL	$13.37 - $18.85 $936,929 - $1.32 Million	-70,077 Reduced 15.45%	383,491 $5.4 Million
Q1 2019 May 15, 2019	SELL	$17.59 - $31.05 $3.06 Million - $5.4 Million	-174,031 Reduced 27.73%	453,568 $8.35 Million
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $8.08 Million - $13.4 Million	426,038 Added 211.37%	627,599 $16.4 Million
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $1.71 Million - $2.16 Million	93,835 Added 87.11%	201,561 $4.63 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $19.15 $130,306 - $178,880	9,341 Added 9.49%	107,726 $2.05 Million
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $150,882 - $216,927	10,739 Added 12.25%	98,385 $1.66 Million
Q4 2017 Feb 12, 2018	SELL	$12.85 - $18.1 $6,604 - $9,303	-514 Reduced 0.58%	87,646 $1.33 Million
Q3 2017 Nov 07, 2017	BUY	$15.4 - $18.85 $1.36 Million - $1.66 Million	88,160	88,160 $1.58 Million

Others Institutions Holding VNDA

# of Institutions

155

Shares Held

43.7M

Call Options Held

33.8K

Put Options Held

28.7K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $269M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Vanda Pharmaceuticals Inc. Transaction History